Short answer · Medically reviewed summary · Last updated: 2026-04-07
Lennox-Gastaut syndrome is a rare, severe form of childhood-onset epilepsy characterized by multiple types of drug-resistant seizures, specific abnormal brain wave patterns known as "slow spike-and-wave" on an EEG, and associated cognitive impairment. It is a lifelong condition that typically requires a multidisciplinary medical approach to manage complex neurological and developmental needs. What exactly is Lennox-Gastaut syndrome? Lennox-Gastaut syndrome (LGS) is a complex epileptic encephalopathy, meaning the frequent seizure activity itself contributes to progressive cognitive and behavioral issues.
Lennox-Gastaut syndrome is a rare, severe form of childhood-onset epilepsy characterized by multiple types of drug-resistant seizures, specific abnormal brain wave patterns known as "slow spike-and-wave" on an EEG, and associated cognitive impairment. It is a lifelong condition that typically requires a multidisciplinary medical approach to manage complex neurological and developmental needs.
Lennox-Gastaut syndrome (LGS) is a complex epileptic encephalopathy, meaning the frequent seizure activity itself contributes to progressive cognitive and behavioral issues. Unlike common childhood epilepsies that may resolve with age, Lennox-Gastaut syndrome is chronic and often resistant to standard anti-seizure medications. Patients with this condition experience a wide variety of seizure types, which can occur throughout the day and night, significantly impacting daily functioning and quality of life.
Lennox-Gastaut syndrome usually begins in early childhood, typically between the ages of 3 and 5 years, though it can manifest as early as infancy or as late as adolescence. Current data suggests it affects approximately 1 to 2 per 100,000 individuals in the general population, accounting for about 1% to 5% of all childhood epilepsy cases. While it affects both males and females, some clinical studies note a slightly higher prevalence in males. It is found globally across all ethnic and geographic populations.
The pathophysiology of Lennox-Gastaut syndrome is diverse, as it is often a "final common pathway" for various underlying brain injuries or genetic mutations rather than a single disease process. In many cases, the cause is identifiable, while in others, it remains unknown. Common underlying factors include:
What sets Lennox-Gastaut syndrome apart from more common forms of epilepsy is the triad of symptoms: multiple seizure types (specifically tonic, atonic, and atypical absence seizures), characteristic "slow spike-and-wave" patterns on an electroencephalogram (EEG), and developmental delay or intellectual disability. While many children with epilepsy achieve seizure freedom with medication, seizures associated with Lennox-Gastaut syndrome are notoriously difficult to control, and many patients experience "drop attacks" (atonic seizures) that pose a high risk of physical injury.
At DiseaseMaps.org, we recognize the isolation that can accompany a rare diagnosis. Currently, 105 people with Lennox-Gastaut syndrome have joined our community, sharing their experiences, treatment journeys, and strategies for navigating the complexities of this condition. Connecting with others who understand the unique challenges of Lennox-Gastaut syndrome can be a vital part of your care journey.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.